These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 23800582

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dabigatran overdose secondary to acute kidney injury and amiodarone use.
    Fountzilas C, George J, Levine R.
    N Z Med J; 2013 Mar 01; 126(1370):110-2. PubMed ID: 23474519
    [Abstract] [Full Text] [Related]

  • 3. Gastrointestinal bleeding under dabigatran.
    Stöllberger C, Lindner K, Finsterer J.
    J Postgrad Med; 2014 Mar 01; 60(2):192-3. PubMed ID: 24823522
    [Abstract] [Full Text] [Related]

  • 4. Direct thrombin inhibitors: a case indicating benefit from 'plasmapheresis' in toxicity: a call for establishing "guidelines" in overdose and to find an "antidote"!
    Kamboj J, Kottalgi M, Cirra VR, Shah N, Kamboj R.
    Am J Ther; 2012 Nov 01; 19(6):e182-5. PubMed ID: 23154229
    [Abstract] [Full Text] [Related]

  • 5. Ischemic stroke in an obese patient receiving dabigatran.
    Breuer L, Ringwald J, Schwab S, Köhrmann M.
    N Engl J Med; 2013 Jun 20; 368(25):2440-2. PubMed ID: 23782198
    [No Abstract] [Full Text] [Related]

  • 6. Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation.
    Lillo-Le Louët A, Wolf M, Soufir L, Galbois A, Dumenil AS, Offenstadt G, Samama MM.
    Thromb Haemost; 2012 Sep 20; 108(3):583-5. PubMed ID: 22782645
    [No Abstract] [Full Text] [Related]

  • 7. [Dabigatran as cause of severe gastrointestinal bleeding in a Jehovah's Witness patient].
    Holm J, Taskiran M.
    Ugeskr Laeger; 2013 Feb 04; 175(6):334-6. PubMed ID: 23402236
    [Abstract] [Full Text] [Related]

  • 8. Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention.
    Stöllberger C, Rakusan S, Wimpissinger FT, Finsterer J.
    Thromb Haemost; 2012 Sep 04; 108(3):579-81. PubMed ID: 22739630
    [No Abstract] [Full Text] [Related]

  • 9. Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.
    Wychowski MK, Kouides PA.
    Ann Pharmacother; 2012 Apr 04; 46(4):e10. PubMed ID: 22496474
    [Abstract] [Full Text] [Related]

  • 10. Dabigatran in patients with nonvalvular atrial fibrillation.
    Gage L.
    J Am Coll Cardiol; 2011 Jul 26; 58(5):551; author reply 551. PubMed ID: 21777759
    [No Abstract] [Full Text] [Related]

  • 11. Dabigatran-induced upper intestinal bleeding in a patient with chronic kidney disease.
    Ribés-Cruz JJ, Torregrosa-Maicas I, Ramos-Tomás C, Solís-Salguero MA, Puchades-Montesa MJ, González-Rico MA, Juan-García I, Tomás-Simó P, Tejedor-Alonso S, Zambrano-Esteves P, Miguel-Carrasco A.
    Nefrologia; 2013 Nov 13; 33(6):864-6. PubMed ID: 24241382
    [No Abstract] [Full Text] [Related]

  • 12. Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation.
    Bendel SD, Bona R, Baker WL.
    Adv Ther; 2011 Jun 13; 28(6):460-72. PubMed ID: 21533567
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Risk of major bleeding and the standard doses of dabigatran.
    Antoniazzi S, Berdaï D, Conti V, Clementi E, Salvo F.
    Eur J Intern Med; 2014 Jul 13; 25(6):e73-5. PubMed ID: 24629895
    [No Abstract] [Full Text] [Related]

  • 15. [Anticoagulant therapy in connection with cardioversion in patients with atrial fibrillation].
    Furman NV, Kuvshinova LE, Dovgalevskiĭ IaP.
    Kardiologiia; 2012 Jul 13; 52(9):69-76. PubMed ID: 23098549
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluating and assessing dabigatran drug interactions.
    Nguyen T, Wong E.
    Consult Pharm; 2012 Jul 13; 27(7):509-12. PubMed ID: 22910132
    [Abstract] [Full Text] [Related]

  • 18. Dabigatran-induced acute hepatitis.
    Rochwerg B, Xenodemetropoulos T, Crowther M, Spyropoulos A.
    Clin Appl Thromb Hemost; 2012 Sep 13; 18(5):549-50. PubMed ID: 22962308
    [No Abstract] [Full Text] [Related]

  • 19. The importance of postapproval data for dabigatran.
    Redberg RF.
    JAMA Intern Med; 2015 Jan 13; 175(1):25. PubMed ID: 25365377
    [No Abstract] [Full Text] [Related]

  • 20. Ischemic stroke and intestinal bleeding under dabigatran in metabolic myopathy.
    Finsterer J, Stöllberger C, Paul G, Bastovansky A.
    Cardiovasc Ther; 2013 Dec 13; 31(6):e111-4. PubMed ID: 24279385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.